WO2024261648 - MULTIVALENT SUBTYPE INFLUENZA VACCINE
National phase entry:
Publication Number
WO/2024/261648
Publication Date
26.12.2024
International Application No.
PCT/IB2024/055964
International Filing Date
19.06.2024
Title **
[English]
MULTIVALENT SUBTYPE INFLUENZA VACCINE
[French]
VACCIN CONTRE LA GRIPPE DE SOUS-TYPE MULTIVALENT
Applicants **
SEQIRUS INC.
475 Green Oaks Parkway
Holly Springs NC, North Carolina 27540, US
Inventors
ROCKMAN, Steven
c/o Seqirus Inc.
475 Green Oaks Parkway
Holly Springs, North Carolina 27540, US
LAURIE, Karen
c/o Seqirus Inc.
475 Green Oaks Parkway
Holly Springs, North Carolina 27540, US
MCMAHON, Meagan
c/o Seqirus Inc.
475 Green Oaks Parkway
Holly Springs, North Carolina 27540, US
Priority Data
2023901936
19.06.2023
AU
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
IP Australia
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 2007 | |
| EPO | Filing, Examination | 14698 | |
| Japan | Filing | 594 | |
| South Korea | Filing | 575 | |
| USA | Filing, Examination | 8110 |
Total: 25984 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
The present disclosure relates to multivalent subtype influenza vaccines to treat and prevent influenza-associated diseases, disorders or conditions.[French]
La présente invention concerne des vaccins contre la grippe de sous-type multivalents pour traiter et prévenir des maladies, des troubles ou des états associés à la grippe.